Abstract Plasma lipoprotein (a)(Lp (a)) is a quantitative trait associated with atherothrombotic
disease in European and Asian populations. Lp (a) concentrations vary widely within and …

Abstract Lipoprotein (a)[Lp (a)] is a quantitative genetic trait in human plasma associated
with atherothrombotic disease. The major determinant of Lp (a) concentration is the …

OBJECTIVES: The LPA I4399M (rs3798220) single nucleotide polymorphism (SNP) is
associated with increased plasma levels of Lp (a) and advanced coronary artery disease …

Abstract Background Lipoprotein (a)(Lp (a)) is recognized as a causal factor for coronary
heart disease (CHD) but its atherogenicity relative to that of low-density lipoprotein (LDL) on …

Levels of lipoprotein (a)[Lp (a)], a complex between an LDL-like lipid moiety containing one
copy of apoB, and apo (a), a plasminogen-derived carbohydrate-rich hydrophilic protein, are …

Abstract Plasma lipoprotein [a](Lp [a]) concentrations are inversely associated with, and
largely determined by, apolipoprotein [a](apo [a]) gene size, a highly polymorphic trait. We …

Lipoprotein (a) or Lp (a) is a genetic variant of plasma low density lipoproteins (LDL)
containing apoB100 covalently linked to apolipoprotein (a) or apo (a), the specific marker of …

Increased lipoprotein (a)(Lp (a)) levels are an independent predictor of coronary artery
disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD …

Abstract Lipoprotein (a)[Lp (a)] concentrations are regulated by the LPA gene mainly via the
large kringle IV-type 2 (KIV-2) copy number variation and multiple causal variants. Early …

(Arterioscler Thromb Vasc Biol. 2012; 32: 1550–1551.) angiographically, but carotid stenosis
(≥ 50%) was assessed by Doppler ultrasound, and peripheral vascular disease by …